Back to Newsroom

Alder BioPharmaceuticals to Present at Wells Fargo 2015 Healthcare Conference

BOTHELL, Wash., September 2, 2015 – Alder BioPharmaceuticals, Inc. (“Alder”) (NASDAQ: ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases, today announced that Randall C. Schatzman, Ph.D., President and Chief Executive Officer, will present at the Wells Fargo 2015 Healthcare Conference on Wednesday, September 9, 2015 at 9:25 a.m. ET in Boston, MA.

Click here to read more